Skip to main content

MED

MercyOne Receives Multiple Awards from the American Heart Association

Jul 22, 2019 01:19PM ● By Alyssa McGinnis
MercyOne Siouxland Heart and Vascular Center has received a Gold Plus rating with the American Heart Association's (AHA) 2019 Get with the Guidelines- Heart Failure and special mention for the Target: Heart Failure Honor Roll award. A Gold Plus rating recognizes MercyOne's consistent compliance with AHA's quality measures.

Hospitals with the Gold Plus award have reached an aggressive goal of treating patients with 85 percent or higher compliance to core standard levels of care as outlines by AHA for two consecutive calendar years and have demonstrated 75 percent compliance to during the 12 month period. MercyOne has achieved all three Target components for more than 50 percent or more of eligible patients with heart failure discharged from the hospital consistent with the time frame that is associated with the achievement award being submitted.

Also, MercyOne Siouxland has received an AHA Gold rating for the 2019 Mission: Lifeline- STEMI Receiving Center, which is one of the highest awards for treating the most critical patients with heart issues.

Every year hundreds of thousands of people experience an ST elevation myocardial infarction (STEMI), the deadliest type of heart attack caused by a blockage of blood flow to the heart, that requires timely treatment. To prevent death, it is critical to restore blood flow as quickly as possible, either by mechanically opening the blocked vessel or by providing clot-busting medication.

MercyOne Siouxland also earned the Mission Lifeline NSTEMI Gold Performance achievement award by meeting specific criteria and standards of performance for quick and appropriate treatment of NSTEMI heart attack patients.  MercyOne Siouxland provides procedures and medications to re-establish blood flow to partially blocked arteries when needed and with appropriate medications and follow through after a heart attack, including cardiac rehab, dual antiplatelet therapy and smoking cessation counseling.